Company Events

03/2023

Dr. Grant (Guohua) Xiong was interviewed by Indiana BioFutures 2023, the official magazine of the Indiana Health Industry Forum (IHIF) which was co-edited with the Indianapolis Business Journal (IBJ). Link: https://issues.ibj.com/ibj/magazines/bio-futures/2023/ — Page 29: Femtera strives for early detection of cancer relapse.

04/2022

Congratulations to Dr. Grant (Guohua) Xiong on his achievement of a professional certificate from the renowned National Registry of Certified Chemists (NRCC) as a certified Toxicological Chemist.

03/2021

Femtera became a member of the Indiana Health Industry Forum IHIF (https://ihif.org/ ), a statewide trade association representing Indiana’s health science business community.

12/2020

Two international PCT patent applications were submitted (based on the U.S. provisional patent applications).

10/2020

Dr. Xiong was accepted to attend the FREE AXIS mentoring program (https://biocrossroads.com/axis/), which is a cooperative effort of the top Indiana research institutions and relevant supporting organizations. The program specifically focuses on developing Indiana’s life sciences entrepreneurial talents.

09/2020

Signing a 5-year agreement with research groups from Harvard University School of Medicine - McLean Hospital for providing testing services and developing extended collaborations.

01/2019

Two U.S. provisional patent applications were submitted.

09/2018

Moving into the Biotechnology Research & Training Center (BRTC) of Indiana University School of Medicine.

07/2017

Receiving an A- round VC funding

12/2016

Becoming a resident company of the Indiana Center for Biomedical Innovation (ICBI)

03/2016

Becoming a Co-space Member of the Purdue Research Park (PRP)

03/2016

Being registered with the State of Indiana